Zentek Ltd Stock Price, News & Analysis

Zentek (Nasdaq:ZTEK) announced the immediate resignation of CEO Greg Fenton, who will transition to lead Altek Advanced Materials, a U.S.-based private company where he holds over 50% equity interest. The company has entered into a non-exclusive licensing agreement LOI with Altek for commercializing Zentek's technologies, including ZenGUARD™, in the United States.

The LOI includes a 5-year initial term with a 5-year renewal option and royalties between 5-8% of net sales. CFO Wendy Ford will serve as interim CEO while the board conducts a comprehensive search for a permanent replacement. Fenton will join Zentek's Advisory Board and continue providing strategic guidance through his Consulting Agreement until March 31, 2026.

Zentek (Nasdaq:ZTEK) announced changes to its Board of Directors. Ilse Treurnicht has resigned from the Board effective immediately but will continue serving on the Zentek Advisory Board. John Snisarenko has been appointed as Company Secretary and Chair of the Corporate Governance, Compensation and Nominating Committee.

Additionally, Lisa Sim will not stand for re-election as director but will join the Advisory Board to continue managing the company's intellectual property portfolio. The Board is reviewing new nomination candidates proposed by shareholders. The company will amend and re-mail proxy voting information for the upcoming annual and special meeting scheduled for September 25, 2025.

Zentek (NASDAQ:ZTEK) announced its subsidiary Albany Graphite Corp. (AGC) has been awarded a $500,000 grant from Ontario's Critical Minerals Innovation Fund for graphite purification and anode development. The project includes $314,500 contribution from AGC and $200,000 in-kind support from Natural Resources Canada.

The project aims to produce 5-6 tonnes of flotation concentrate and involves testing with NRCan's electrothermal fluidized bed reactor. AGC recently achieved a significant milestone with 99.9991% purity in preliminary testing, notably without using chlorine gas. The company is positioning itself in the North American battery supply chain, with potential applications in EV batteries, which require up to 125 kg of graphite per vehicle.

Zentek Ltd. (Nasdaq: ZTEK) has received notification from Nasdaq that it is not compliant with the minimum bid price requirement, as its shares have traded below US$1.00 for 31 consecutive business days. The company has until February 23, 2026 to regain compliance by maintaining a closing bid price of at least US$1.00 for 10 consecutive business days.

If Zentek fails to meet this deadline, it may be eligible for an additional 180-day grace period if it meets other listing requirements and provides written notice to Nasdaq. The notification is not an immediate delisting notice, and the company's shares continue to trade on the Nasdaq Capital Market while management explores options to regain compliance.

Zentek (NASDAQ:ZTEK) announced that CEO Greg Fenton's consulting contract will not be extended beyond its expiration date of March 31, 2026. The board of directors has initiated a search for his successor, while the current executive team continues to lead the company in the interim.

Fenton served as CEO for seven years, during which he guided the company's growth and diversification. The board emphasized its commitment to appointing a new CEO who will focus on transitioning Zentek from research and development to commercialization.

Zentek (NASDAQ:ZTEK) announced a regulatory update regarding its ZenGUARD™ Enhanced Air Filters in Canada. Health Canada is currently evaluating the product's classification and has requested additional information from the company.

Previously, on October 31, 2024, Zentek had withdrawn its submission from the Health Canada Pest Management Regulatory Agency (PMRA) to pursue an alternative commercialization pathway. The company subsequently announced on November 27, 2024, its intention to market the air filters as a Class I medical device under its existing Medical Device Establishment License (MDEL), similar to its surgical masks.

Zentek (NASDAQ:ZTEK) announced positive test results for their ZenGUARD Enhanced Air Filters, demonstrating superior viral filtration efficiency against bacteriophage MS2. Independent testing by LMS Technologies showed ZenGUARD filters achieved 42% infectious aerosol removal efficiency compared to 16% for untreated filters. The technology complies with ASHRAE Standard 241-2023 for controlling infectious aerosols while maintaining energy efficiency. ZenGUARD's unique advantages include compatibility with existing HVAC systems, no additional equipment requirements, extended filter life, and reduced maintenance costs. The solution allows facilities to meet air quality standards without upgrading to MERV 11A or higher filters, offering a cost-effective approach to improving indoor air quality while reducing carbon emissions.

Zentek (NASDAQ:ZTEK) has signed a three-year agency agreement with RSK Environment Ltd. on May 7, 2025, enabling RSK to market and promote ZenGUARD™ Enhanced Air Filters in over 20 countries. The partnership focuses on key global markets, including the Gulf Cooperation Council (GCC) region. Under the agreement, Zentek maintains manufacturing and fulfillment responsibilities, while RSK receives a fixed commission on sales within designated territories.

This partnership complements Zentek's existing agreements with Saudi-based Filtration Solutions Industrial Co. and Levidian, strengthening the company's presence in the GCC region. The collaboration aims to align advanced HVAC filtration solutions with regional sustainability and infrastructure objectives.

Zentek Ltd. (NASDAQ: ZTEK, TSXV: ZEN) has completed the sale of its corporate office and laboratory space property located at 24 Corporate Court in Guelph, Ontario. The transaction, which was previously announced on April 17, 2025, was finalized for a purchase price of $2.5 million. As part of the agreement, Zentek will lease back the property from the buyer until January 31, 2026, ensuring uninterrupted operations during the transition period. The company has stated that the sale will not disrupt its daily operations or affect its staff, and plans for relocation after the leaseback period will be announced in the future.